NUKKW vs OMDA
Comparison between Nukkleus Inc - Warrants (22/12/2028) (NUKKW, Company) and Omada Health Inc (OMDA, Company).
NUKKW vs OMDA - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
NUKKW
$1.41B
OMDA
$1.41B
Max Drawdown
NUKKW
96.10%
Winner
OMDA
59.15%
Sharpe Ratio
Winner
NUKKW
0.71
OMDA
0.69
5Y Beta
NUKKW
N/A
OMDA
1.08
Industry
NUKKW
N/A
OMDA
Health Information Services
P/E Ratio
NUKKW
N/A
OMDA
-216.92
Forward P/E
NUKKW
N/A
OMDA
769.23
Debt to Equity
NUKKW
N/A
OMDA
0.00%
Free Cash Flow Yield
NUKKW
N/A
OMDA
-1.08%
P/S Ratio
Winner
NUKKW
0.49
OMDA
4.98
P/B Ratio
NUKKW
N/A
OMDA
5.95
NUKKW vs OMDA - Historical Returns
Returns include dividend reinvestment.
1M
NUKKW
+17.18%
Winner
OMDA
+27.86%
3M
NUKKW
+3.74%
Winner
OMDA
+60.88%
6M
NUKKW
-35.00%
Winner
OMDA
+47.09%
1Y
NUKKW
-11.86%
Winner
OMDA
+26.95%
Max(CAGR)
NUKKW
-27.47%
Winner
OMDA
-0.04%
NUKKW vs OMDA - Annual Returns (2023 - 2026)
Returns include dividend reinvestment.
| Year | NUKKW | OMDA |
|---|---|---|
| 2026 | -33.44% | +54.30% |
| 2025 | -33.28% | -31.39% |
| 2024 | +104.35% | N/A |
| 2023 | -32.19% | N/A |
NUKKW vs OMDA Drawdown Comparison
The maximum drawdown for NUKKW was -96.10%, occurring on Dec 2, 2024. Recovery took 246 trading sessions.
The maximum drawdown for OMDA was -59.15%, occurring on Feb 11, 2026. This drawdown has not yet recovered.
The current NUKKW drawdown is -75.54%. The current OMDA drawdown is -14.15%.
| Rank | NUKKW | OMDA |
|---|---|---|
| #1 | -96.10% Dec 26, 2023 - Dec 18, 2024 | -59.15% Oct 28, 2025 - Feb 11, 2026 |
| #2 | -83.36% Dec 19, 2024 - Jun 10, 2026 | -35.43% Jun 6, 2025 - Aug 27, 2025 |
| #3 | N/A | -11.12% Sep 5, 2025 - Oct 14, 2025 |
| #4 | N/A | -1.97% Oct 15, 2025 - Oct 23, 2025 |
| #5 | N/A | -0.88% Sep 2, 2025 - Sep 5, 2025 |
Correlation
Correlation between NUKKW and OMDA is 0.22 which considered as a very weak or no correlation - the stocks move independently of each other.
0.22
-101
Select Stocks to Compare
Popular: NUKKW vs SPYOMDA vs SPY
More Comparisons
Compare with similar stocks